Apellis Pharmaceuticals Inc (APLS)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

100 FIFTH AVENUE WALTHAM, MA 02451

Apellis Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company focuses on the discovery and development of therapeutic compounds for autoimmune and inflammatory diseases. Apellis Pharmaceuticals serves clients worldwide.

Data as of 2021-04-17 11:11:20 -0400
Market Cap3.663 Billion Shares Outstanding80.375 Million Avg 30-day Volume730.464 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-6.43 Enterprise Value
Total Cash Current Debt Gross Profit
BETA1.22188 52-week High/Low58.47 / 25.49 Next Earnings Date2021-04-29 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from APLS instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 2 150.0% 3 (0.18%) 0 (0.0%)
Funds Holding: 163 143 13.99% 57 (3.43%) 51 (3.18%) 11.76%
13F shares: 62.508 Million 61.496 Million 1.65% 32.149 Million 33.431 Million -3.83%
% Ownership 82.5335 81.1972 1.65% 42.4481 44.1406 -3.83%
New Positions: 36 20 80.0% 15 14 7.14%
Increased Positions 47 49 -4.08% 11 13 -15.38%
Closed Positions 13 18 -27.78% 9 10 -10.0%
Reduced Positions 59 49 20.41% 23 17 35.29%
Total Calls 286.072 Thousand 259.096 Thousand 10.41% 45.5 Thousand 152.7 Thousand -70.2%
Total Puts 122.113 Thousand 121.701 Thousand 0.34% 42.3 Thousand 41.9 Thousand 0.95%
PUT/CALL Ratio 0.43 0.47 -8.51% 0.93 0.27 244.44%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding APLS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APLS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

18 Thousand total shares from 8 transactions

Exercise Derivative Conversion (M)

66.7 Thousand total shares from 6 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DUNLOP A. SINCLAIR

  • Director
617,301 2021-04-16 4

GROSSI FEDERICO CHIEF MEDICAL OFFICER

  • Officer
56,214 2021-04-14 21

DELONG MARK JEFFREY SENIOR VICE PRESIDENT

  • Officer
8,698 2021-03-30 1

BROWN VICTORIA L. PROGRAM TEAM LEAD

  • Officer
9,952 2021-03-25 5

WATSON DAVID O. GENERAL COUNSEL

  • Officer
109,193 2021-03-22 5

MACHIELS ALEC

  • Director
821,523 2021-03-15 11

DESCHATELETS PASCAL CHIEF SCIENTIFIC OFFICER

  • Officer
1,257,336 2021-03-10 3

PERRY NICOLE D VICE PRESIDENT - ACCOUNTING

  • Officer
13,508 2021-03-01 6

EISELE JEFFREY EXEC VP, PROGRAM TEAM LEAD

  • Officer
14,961 2021-03-01 4

FRANCOIS CEDRIC CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,454,244 2021-02-10 14

SULLIVAN TIMOTHY EUGENE CHIEF FINANCIAL OFFICER

  • Officer
34,261 2021-02-10 2

SCHEIBLER LUKAS CHIEF INNOVATION OFFICER

  • Officer
29,290 2021-02-10 3

TOWNSEND ADAM J. CHIEF COMMERCIAL OFFICER

  • Officer
18,865 2021-02-10 2

LEWIS KAREN CHIEF PEOPLE OFFICER

  • Officer
6,250 2021-01-28 2

NICHOLSON NUR CHIEF TECHNICAL OFFICER

  • Officer
9,375 2021-01-28 2

CHAN GERALD

  • Director
0 2021-01-01 1

O'BRIEN STEPHANIE MONAGHAN

  • Director
0 2021-01-01 1

FONTEYNE PAUL R.

  • Director
0 2021-01-01 2

LACKNER THOMAS A. SEE REMARKS

  • Officer
7,725 2020-02-10 0

SADR AHMAD SEE REMARKS

  • Officer
2,725 2020-02-10 0

CELONA LUCIA SEE REMARKS

  • Officer
5,213 2020-02-10 0

MORNINGSIDE VENTURE INVESTMENTS LTD

  • 10% Owner
12,556,342 2020-01-13 0

AXON STEVEN CHIEF BUSINESS OFFICER

  • Officer
50,110 2018-11-14 0

AJU IB INVESTMENT CO., LTD.

  • 10% Owner
No longer subject to file 2017-11-13 0

VENBIO GLOBAL STRATEGIC FUND II L.P.

  • 10% Owner
No longer subject to file 2017-11-13 0

GELLERT MICHAEL E

  • 10% Owner
No longer subject to file 2017-11-13 0

HILLHOUSE CAPITAL MANAGEMENT, LTD.

  • 10% Owner
No longer subject to file 2017-11-13 0

CORMORANT ASSET MANAGEMENT, LLC

CHEN BIHUA

CORMORANT GLOBAL HEALTHCARE GP, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

  • Director
  • 10% Owner
No longer subject to file 2017-11-13 0

CORMORANT ASSET MANAGEMENT, LLC

CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

CORMORANT PRIVATE HEALTHCARE FUND I, LP

CHEN BIHUA

  • Director
  • 10% Owner
0 2017-11-08 0

POTENTIA HOLDINGS, LLC

  • 10% Owner
3,826,601 2017-11-08 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DUNLOP A. SINCLAIR - Director

2021-04-19 19:29:54 -0400 2021-04-16 M 50,000 $14.00 a 50,000 direct

DUNLOP A. SINCLAIR - Director

2021-04-19 19:29:54 -0400 2021-04-16 M 50,000 d 71,894 direct

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-04-15 17:55:38 -0400 2021-04-14 S 500 $42.82 d 56,214 direct yes 0.8997 0.8997 2 0.0 1

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-04-05 17:11:27 -0400 2021-04-01 S 600 $43.41 d 56,714 direct yes -1.2793 1.9551 1.9551 6 -1.2793 2

BROWN VICTORIA L. - Officer PROGRAM TEAM LEAD

2021-03-29 16:58:35 -0400 2021-03-25 F 82 $41.16 d 9,952 direct 2.0452 -2.7348 2.9727 3 -2.7348 6

WATSON DAVID O. - Officer GENERAL COUNSEL

2021-03-23 16:14:39 -0400 2021-03-22 M 978 d 2,421 direct

WATSON DAVID O. - Officer GENERAL COUNSEL

2021-03-23 16:14:39 -0400 2021-03-22 M 978 $4.31 a 96,772 direct 0.8824 5.1716 6.7157 4 0.0 1

MACHIELS ALEC - Director

2021-03-17 16:16:51 -0400 2021-03-15 S 2,500 $46.77 d 669,544 direct yes -0.1136 -6.4545 0.0 1 -7.2727 5

MACHIELS ALEC - Director

2021-03-17 16:16:51 -0400 2021-03-15 M 2,500 $2.67 a 672,044 direct yes -0.1136 -6.4545 0.0 1 -7.2727 5

MACHIELS ALEC - Director

2021-03-17 16:16:51 -0400 2021-03-15 M 2,500 d 150,029 direct yes

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-03-17 16:14:52 -0400 2021-03-15 S 500 $46.77 d 57,314 direct yes -0.1136 -6.4545 0.0 1 -7.2727 5

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-03-11 16:08:41 -0500 2021-03-10 M 6,250 d 392,249 direct

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-03-11 16:08:41 -0500 2021-03-10 S 6,250 $50.74 d 865,087 direct 0.9644 -5.808 0.9644 2 -5.808 6

DESCHATELETS PASCAL - Officer CHIEF SCIENTIFIC OFFICER

2021-03-11 16:08:41 -0500 2021-03-10 M 6,250 $2.67 a 871,337 direct 0.9644 -5.808 0.9644 2 -5.808 6

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-03-08 16:32:29 -0500 2021-03-05 M 5,000 d 34,073 direct

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-03-08 16:32:29 -0500 2021-03-05 S 5,000 $48.62 d 57,814 direct 6.0066 -5.6545 6.0066 2 -5.6545 6

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-03-08 16:32:29 -0500 2021-03-05 M 5,000 $3.20 a 62,814 direct 6.0066 -5.6545 6.0066 2 -5.6545 6

GROSSI FEDERICO - Officer CHIEF MEDICAL OFFICER

2021-03-03 16:03:47 -0500 2021-03-01 S 600 $48.58 d 57,814 direct yes 6.9222 9.5728 -0.1752 12.1139 5 -10.6243 15

BROWN VICTORIA L. - Officer PROGRAM TEAM LEAD

2021-03-19 17:58:14 -0400 2021-03-01 A 7,500 a 7,500 direct

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-03-03 16:05:16 -0500 2021-03-01 M 2,000 d 11,161 direct yes

EISELE JEFFREY - Officer EXEC VP, PROGRAM TEAM LEAD

2021-03-03 16:07:02 -0500 2021-03-01 A 7,500 a 7,500 direct

BROWN VICTORIA L. - Officer PROGRAM TEAM LEAD

2021-03-19 17:58:14 -0400 2021-03-01 A 1,250 a 10,034 direct -2.4651 1.2558 1.2558 6 -5.1163 3

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-03-03 16:05:16 -0500 2021-03-01 S 2,000 $50.00 d 2,347 direct yes 6.9222 9.5728 -0.1752 12.1139 5 -10.6243 15

EISELE JEFFREY - Officer EXEC VP, PROGRAM TEAM LEAD

2021-03-03 16:07:02 -0500 2021-03-01 A 1,250 a 7,461 direct 6.9222 9.5728 -0.1752 12.1139 5 -10.6243 15

PERRY NICOLE D - Officer VICE PRESIDENT - ACCOUNTING

2021-03-03 16:05:16 -0500 2021-03-01 M 2,000 $3.76 a 4,347 direct yes 6.9222 9.5728 -0.1752 12.1139 5 -10.6243 15

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 22:15:03 UTC -0.2094 0.2694 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 21:45:03 UTC -0.2097 0.2697 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 21:15:02 UTC -0.2097 0.2697 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 20:45:03 UTC -0.2204 0.2804 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 20:15:04 UTC -0.2204 0.2804 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 19:45:03 UTC -0.2204 0.2804 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 19:15:03 UTC -0.2204 0.2804 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 18:45:03 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 18:15:03 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 17:45:02 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 17:15:02 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 16:45:03 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 16:15:03 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 15:45:03 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 15:15:02 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 14:45:03 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 14:15:03 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 13:45:03 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 13:15:04 UTC -0.19 0.25 550000
APELLIS PHARMACEUTICALS INC APLS 2021-04-20 12:45:03 UTC -0.19 0.25 550000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund APLS -20700.0 shares, $-975798.0 2020-11-30 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio APLS -3467.0 shares, $-198312.4 2020-12-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund APLS -24550.0 shares, $-1404260.0 2020-12-31 N-PORT
Trust for Professional Managers- Convergence Market Neutral Fund APLS -2152.0 shares, $-66346.16 2020-08-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund APLS -192.0 shares, $-5792.64 2020-09-30 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund APLS -20045.0 shares, $-1146574.0 2020-12-31 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund APLS -6484.0 shares, $-287046.68 2021-01-29 N-PORT

Elevate your investments